Why the study?
Respiratory depression is a major concern with opioid use, necessitating guidelines for their safe clinical application.
Provides guidelines for the safe use of opioids to mitigate the risk of respiratory depression.
No takes yet. Share an insight, caveat, or question.
Guidelines may encourage indicated opioid use despite respiratory depression fears; leaves open prospective validation of these recommendations.
Albert Dahan (2007) studied this question. Opioids can be safely prescribed when clinically indicated by following established guidelines, despite the feared risk of respiratory depression.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: